HEADER HYDROLASE/HYDROLASE INHIBITOR 09-APR-13 4K2Y TITLE CRYSTAL STRUCTURE OF HUMAN CHYMASE IN COMPLEX WITH FRAGMENT INHIBITOR TITLE 2 6-CHLORO-1,3-DIHYDRO-2H-INDOL-2-ONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHYMASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 22-247; COMPND 5 SYNONYM: ALPHA-CHYMASE, MAST CELL PROTEASE I; COMPND 6 EC: 3.4.21.39; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CMA1, CYH, CYM; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PDEST1393 KEYWDS SERINE PROTEASE, GLYCOSYLATED, MAST CELLS, SECRETED, HYDROLASE- KEYWDS 2 HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR B.K.COLLINS,A.K.PADYANA REVDAT 5 06-NOV-24 4K2Y 1 REMARK HETSYN REVDAT 4 29-JUL-20 4K2Y 1 COMPND REMARK SEQADV HETNAM REVDAT 4 2 1 LINK SITE REVDAT 3 17-JUL-19 4K2Y 1 REMARK LINK REVDAT 2 03-JUL-13 4K2Y 1 JRNL REVDAT 1 29-MAY-13 4K2Y 0 JRNL AUTH S.J.TAYLOR,A.K.PADYANA,A.ABEYWARDANE,S.LIANG,M.H.HAO, JRNL AUTH 2 S.DE LOMBAERT,J.PROUDFOOT,B.S.FARMER,X.LI,B.COLLINS, JRNL AUTH 3 L.MARTIN,D.R.ALBAUGH,M.HILL-DRZEWI,S.S.PULLEN,H.TAKAHASHI JRNL TITL DISCOVERY OF POTENT, SELECTIVE CHYMASE INHIBITORS VIA JRNL TITL 2 FRAGMENT LINKING STRATEGIES. JRNL REF J.MED.CHEM. V. 56 4465 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 23659209 JRNL DOI 10.1021/JM400138Z REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8_1069) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.64 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 90.8 REMARK 3 NUMBER OF REFLECTIONS : 11108 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.780 REMARK 3 FREE R VALUE TEST SET COUNT : 531 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 20.6370 - 3.6463 0.86 2571 126 0.1518 0.2050 REMARK 3 2 3.6463 - 2.8967 0.92 2627 160 0.1845 0.2748 REMARK 3 3 2.8967 - 2.5313 0.93 2683 132 0.2112 0.2905 REMARK 3 4 2.5313 - 2.3000 0.92 2696 113 0.2041 0.2945 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.350 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.910 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 1759 REMARK 3 ANGLE : 1.072 2374 REMARK 3 CHIRALITY : 0.076 261 REMARK 3 PLANARITY : 0.005 303 REMARK 3 DIHEDRAL : 13.757 652 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4K2Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-APR-13. REMARK 100 THE DEPOSITION ID IS D_1000078824. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-MAY-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : VARIMAX HF REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11128 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 41.330 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.8 REMARK 200 DATA REDUNDANCY : 3.540 REMARK 200 R MERGE (I) : 0.15300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.46 REMARK 200 R MERGE FOR SHELL (I) : 0.44100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.75 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 26-33% PEG8000, 0.1 M TRIS, PH 8.0, 2 REMARK 280 MM ZINC SULFATE, VAPOR DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+3/4 REMARK 290 4555 Y,-X,Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 24.85050 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 37.27575 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 12.42525 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PHE A 123 REMARK 465 PRO A 124 REMARK 465 SER A 125 REMARK 465 GLN A 126 REMARK 465 LYS A 127 REMARK 465 ASN A 128 REMARK 465 PHE A 129 REMARK 465 VAL A 130 REMARK 465 PRO A 131 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 40 CD CE NZ REMARK 480 GLU A 75 CG CD OE1 OE2 REMARK 480 ARG A 137 CG CD NE CZ NH1 NH2 REMARK 480 LEU A 147 CG CD1 CD2 REMARK 480 LYS A 159 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 71 -77.26 -119.51 REMARK 500 SER A 214 -69.77 -130.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 301 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 25 NE2 REMARK 620 2 GLU A 78 OE1 117.4 REMARK 620 N 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3S0N RELATED DB: PDB REMARK 900 HUMAN CHYMASE COMPLEXED WITH BENZIMIDAZOLONE INHIBITOR REMARK 900 RELATED ID: 4K5Z RELATED DB: PDB REMARK 900 HUMAN CHYMASE IN COMPLEX WITH FRAGMENT INHIBITOR 6-CHLORO-2,3- REMARK 900 DIHYDRO-1H-ISOINDOL-1-ONE REMARK 900 RELATED ID: 4K60 RELATED DB: PDB REMARK 900 HUMAN CHYMASE IN COMPLEX WITH FRAGMENT 6-BROMO-1,3-DIHYDRO-2H-INDOL- REMARK 900 2-ONE REMARK 900 RELATED ID: 4K69 RELATED DB: PDB REMARK 900 HUMAN CHYMASE IN COMPLEX WITH FRAGMENT LINKED BENZIMIDAZOLONE REMARK 900 INHIBITOR: (3S)-3-{3-[(6-BROMO-2-OXO-2,3-DIHYDRO-1H-INDOL-4-YL) REMARK 900 METHYL]-2-OXO-2,3-DIHYDRO-1H-BENZIMIDAZOL-1-YL}HEXANOIC ACID DBREF 4K2Y A 16 245 UNP P23946 CMA1_HUMAN 22 247 SEQADV 4K2Y LYS A 127 UNP P23946 PHE 135 CONFLICT SEQADV 4K2Y ALA A 208 UNP P23946 VAL 212 CONFLICT SEQADV 4K2Y GLN A 235 UNP P23946 ARG 237 CONFLICT SEQRES 1 A 226 ILE ILE GLY GLY THR GLU CYS LYS PRO HIS SER ARG PRO SEQRES 2 A 226 TYR MET ALA TYR LEU GLU ILE VAL THR SER ASN GLY PRO SEQRES 3 A 226 SER LYS PHE CYS GLY GLY PHE LEU ILE ARG ARG ASN PHE SEQRES 4 A 226 VAL LEU THR ALA ALA HIS CYS ALA GLY ARG SER ILE THR SEQRES 5 A 226 VAL THR LEU GLY ALA HIS ASN ILE THR GLU GLU GLU ASP SEQRES 6 A 226 THR TRP GLN LYS LEU GLU VAL ILE LYS GLN PHE ARG HIS SEQRES 7 A 226 PRO LYS TYR ASN THR SER THR LEU HIS HIS ASP ILE MET SEQRES 8 A 226 LEU LEU LYS LEU LYS GLU LYS ALA SER LEU THR LEU ALA SEQRES 9 A 226 VAL GLY THR LEU PRO PHE PRO SER GLN LYS ASN PHE VAL SEQRES 10 A 226 PRO PRO GLY ARG MET CYS ARG VAL ALA GLY TRP GLY ARG SEQRES 11 A 226 THR GLY VAL LEU LYS PRO GLY SER ASP THR LEU GLN GLU SEQRES 12 A 226 VAL LYS LEU ARG LEU MET ASP PRO GLN ALA CYS SER HIS SEQRES 13 A 226 PHE ARG ASP PHE ASP HIS ASN LEU GLN LEU CYS VAL GLY SEQRES 14 A 226 ASN PRO ARG LYS THR LYS SER ALA PHE LYS GLY ASP SER SEQRES 15 A 226 GLY GLY PRO LEU LEU CYS ALA GLY ALA ALA GLN GLY ILE SEQRES 16 A 226 VAL SER TYR GLY ARG SER ASP ALA LYS PRO PRO ALA VAL SEQRES 17 A 226 PHE THR ARG ILE SER HIS TYR GLN PRO TRP ILE ASN GLN SEQRES 18 A 226 ILE LEU GLN ALA ASN MODRES 4K2Y ASN A 72 ASN GLYCOSYLATION SITE HET ZN A 301 1 HET NAG A 302 14 HET ES2 A 303 11 HETNAM ZN ZINC ION HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM ES2 6-CHLORO-1,3-DIHYDRO-2H-INDOL-2-ONE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 ZN ZN 2+ FORMUL 3 NAG C8 H15 N O6 FORMUL 4 ES2 C8 H6 CL N O FORMUL 5 HOH *207(H2 O) HELIX 1 1 ALA A 55 ALA A 59 5 5 HELIX 2 2 ASP A 164 SER A 169 5 6 HELIX 3 3 ILE A 231 ALA A 244 1 14 SHEET 1 A 8 THR A 20 GLU A 21 0 SHEET 2 A 8 GLN A 156 MET A 163 -1 O GLU A 157 N THR A 20 SHEET 3 A 8 GLN A 180 VAL A 183 -1 O CYS A 182 N MET A 163 SHEET 4 A 8 ALA A 226 ARG A 230 -1 O PHE A 228 N LEU A 181 SHEET 5 A 8 ALA A 208 TYR A 215 -1 N TYR A 215 O VAL A 227 SHEET 6 A 8 PRO A 198 CYS A 201 -1 N LEU A 199 O GLN A 210 SHEET 7 A 8 MET A 135 GLY A 140 -1 N ARG A 137 O LEU A 200 SHEET 8 A 8 GLN A 156 MET A 163 -1 O LEU A 160 N CYS A 136 SHEET 1 B 7 MET A 30 VAL A 36 0 SHEET 2 B 7 LYS A 40 ARG A 48 -1 O LYS A 40 N ILE A 35 SHEET 3 B 7 PHE A 51 THR A 54 -1 O LEU A 53 N PHE A 45 SHEET 4 B 7 MET A 104 LEU A 108 -1 O LEU A 106 N VAL A 52 SHEET 5 B 7 GLN A 81 ARG A 90 -1 N PHE A 89 O LEU A 105 SHEET 6 B 7 SER A 63 LEU A 68 -1 N VAL A 66 O LEU A 83 SHEET 7 B 7 MET A 30 VAL A 36 -1 N VAL A 36 O SER A 63 SSBOND 1 CYS A 42 CYS A 58 1555 1555 2.04 SSBOND 2 CYS A 136 CYS A 201 1555 1555 2.02 SSBOND 3 CYS A 168 CYS A 182 1555 1555 2.03 LINK ND2 ASN A 72 C1 NAG A 302 1555 1555 1.49 LINK NE2 HIS A 25 ZN ZN A 301 1555 1555 2.26 LINK OE1 GLU A 78 ZN ZN A 301 1555 1555 2.23 CISPEP 1 PRO A 224 PRO A 225 0 2.79 CRYST1 74.405 74.405 49.701 90.00 90.00 90.00 P 43 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013440 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013440 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020120 0.00000